Maine Medical Center
Portland, Maine, 04102, United States
Location status: Recruiting
NCT Number: NCT02820233
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Portland, Maine, 04102, United States
Location status: Recruiting
The EGF family of receptor tyrosine kinases (a.k.a. ERBB receptors) mediate the effects of the epidermal growth factor (EGF) family including Neuregulin-1β (NRG). NRG and ERBB1-4 are critical for cardiac development and maintenance of the adult heart. Current understanding of the role of EGF/NRG/ERBB signaling in the cardiovascular system is rapidly evolving due to recent findings in non-myocyte cell populations. This study is examining a population of progenitor cells in the adult human heart that responds to EGF and NRG. Subjects are enrolled who are scheduled to undergo heart surgery and are willing to allow for a small biopsy to be taken from their hearts during surgery. Biopsies are taken to the laboratory where cells are separated and analyzed by flow cytometry and grown in cell culture to understand how their biology is regulated by NRG and EGF.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 14 days from isolation
Time frame: up to 14 days from isolation
Contact information is provided by the study sponsor or research team.
Douglas B. Sawyer
Other
Isolation and Characterization of ERBB Expressing Human Heart Progenitor Cells
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01096693
Cardiovascular Diseases, Heart Disease
Edinburgh, Mid Lothian, United Kingdom
View Trial DetailsNCT01096706
Cardiovascular Diseases, Heart Disease
Edinburgh, Mid Lothian, United Kingdom
View Trial DetailsNCT01049542
Cardiovascular Diseases, Heart Disease
Edinburgh, Mid Lothian, United Kingdom
View Trial DetailsNCT06675552
Cardiovascular Disease, Cardiovascular Diseases
Berlin, Germany
View Trial Details